Wells Fargo & Company Bio Sig Technologies, Inc. Transaction History

Wells Fargo & Company

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$0.26 - $0.62 $79 - $190	-307 Reduced 36.68%	530 $0
Q3 2023 Nov 13, 2023	SELL	$0.4 - $1.39 $2 - $8	-6 Reduced 0.71%	837 $0
Q2 2023 Aug 15, 2023	BUY	$1.07 - $1.55 $102 - $148	96 Added 12.85%	843 $1,000
Q1 2023 May 12, 2023	SELL	$0.42 - $1.4 $2,078 - $6,927	-4,948 Reduced 86.88%	747 $0
Q4 2022 Feb 13, 2023	BUY	$0.31 - $8.8 $8 - $237	27 Added 0.48%	5,695 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.56 - $6.98 $15 - $188	27 Added 0.48%	5,668 $3,000
Q2 2022 Aug 12, 2022	BUY	$0.63 - $1.22 $27 - $52	43 Added 0.77%	5,641 $3,000
Q1 2022 May 16, 2022	BUY	$0.99 - $2.44 $1,982 - $4,887	2,003 Added 55.72%	5,598 $6,000
Q4 2021 Feb 14, 2022	BUY	$2.18 - $3.93 $4,364 - $7,867	2,002 Added 125.67%	3,595 $8,000
Q3 2021 Nov 15, 2021	SELL	$2.71 - $4.35 $3,233 - $5,189	-1,193 Reduced 42.82%	1,593 $5,000
Q2 2021 Aug 16, 2021	SELL	$2.94 - $4.75 $19,198 - $31,017	-6,530 Reduced 70.09%	2,786 $11,000
Q1 2021 May 13, 2021	SELL	$3.99 - $5.53 $59,470 - $82,424	-14,905 Reduced 61.54%	9,316 $41,000
Q4 2020 Feb 09, 2021	SELL	$2.99 - $5.79 $4,096 - $7,932	-1,370 Reduced 5.35%	24,221 $94,000
Q3 2020 Nov 05, 2020	BUY	$4.79 - $9.1 $76 - $145	16 Added 0.06%	25,591 $127,000
Q2 2020 Aug 13, 2020	SELL	$3.61 - $11.84 $36,042 - $118,210	-9,984 Reduced 28.08%	25,575 $184,000
Q1 2020 May 14, 2020	BUY	$2.56 - $6.14 $91,031 - $218,332	35,559 New	35,559 $149,000

88.1K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $60.1M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.